Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
BlackRock, Inc. reported a 7.10% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 7.10% stake in Amylyx Pharmaceuticals, Inc., 7,783,648 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 7.10%
- Shares
- 7,783,648
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.10% | 7,783,648 |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- BlackRock, Inc.
- Amylyx Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026